An environmental study of single-use process technology for biopharmaceutical manufacturing offers a comprehensive examination of environmental impacts across the full process train using lifecycle assessment.
The authors compare the environmental impact of monoclonal antibody production using fixed-in-place processing and single-use systems.
Comparing the economic feasibility of a typical glycosylated protein.
Sanofi Pasteur's disposables implementation plan is part of a larger evaluation of technology innovation. Here's how they approach it.
An analysis of flow rate, load density, viral clearance, and cost.
How a Big Pharma company tackled the move to disposable bioreactors.
How this Big Pharma company successfully implemented disposable technologies in its manufacturing plant.
Suppliers, manufacturers, and governments must work together to plan how best to develop and deploy disposable systems for emergency response.
Single-use technologies can be configured and installed fairly quickly, but are they ready to handle the urgency and scale of a pandemic?